Obesity-specialist framing with injections, dissolving tablets, and brand-name paths.
Wellorithm is a telehealth weight-management platform built around board-certified obesity-specialist care, with licensed clinician coverage across all 50 states. Its standout is format breadth: alongside compounded semaglutide and tirzepatide injections, it lists needle-free dissolving-tablet (ODT) versions of both medications, plus brand-name medication paths on its site. Support runs around the clock, and everything from consultation to delivery happens online.
You create an account and book a virtual consultation, communicating your history and goals to the clinical team. If treatment is appropriate, your personalized plan and medication ship to your door, with ongoing guidance and progress monitoring through the platform. Billing runs on a recurring 28-day cash-pay cycle, insurance is generally not billed directly, and payments are non-refundable once processed, so read the plan terms before enrolling.
Wellorithm fits best if needles are the obstacle: its dissolving-tablet versions of both semaglutide and tirzepatide are genuinely uncommon in this space, and the brand-name paths give you somewhere to go if you later want an FDA-approved product. The 50-state clinician coverage also matters if you live somewhere thinner on telehealth options. Its $147/mo semaglutide entry is competitive; just go in clear-eyed about the recurring 28-day billing terms.